Clinical and clinical research articleThe effect of Mesterolone (cas 1424-00-6) on sperm count, on serum follicle stimulating hormone, luteinizing hormone, plasma testosterone and outcome in idiopathic oligospermic men

Add time:09/28/2019    Source:sciencedirect.com

Two hundred fifty subfertile men with idiopathic oligospermia (count less than 20 million/ml) were treated with Mesterolone (cas 1424-00-6) (100–150 mg/day) for 12 months. Seminal analysis were assayed 3 times and serum follicle stimulating hormone (FSH) luteinizing hormone (LH) and plasma testosterone were assayed once before treatment and repeated at 3, 6, 9 and 12 months after the initiation of treatment. One hundred ten patients (44%) had normal serum FSH, LH and plasma testosterone, 85 patients (34%) had low serum FSH, LH and low plasma testosterone. One hundred seventy-five patients (70%) had moderate oligospermia (count 5 to <20 million/ml) and 75 patients (30%) had severe oligospermia (count <5 million/ml). Seventy-five moderately oligospermic patients showed significant improvement in the sperm density, total sperm count and motility following mesterolone therapy whereas only 12% showed improvement in the severe oligospermic group. Mesterolone had no depressing effect on low or normal serum FSH and LH levels but had depressing effect on 25% if the levels were elevated. There was no significant adverse effect on testosterone levels or on liver function. One hundred fifteen (46%) pregnancies resulted following the treatment, 9 of 115 (7.8%) aborted and 2 (1.7%) had ectopic pregnancy. Mesterolone was found to be more useful in patients with a sperm count ranging between 5 and 20 million/ml. Those with severe oligospermia (count <5 million) do not seem to benefit from this therapy.

We also recommend Trading Suppliers and Manufacturers of Mesterolone (cas 1424-00-6). Pls Click Website Link as below: cas 1424-00-6 suppliers

Prev:Mesterolone (cas 1424-00-6)
Next:Urology-andrologyPlacebo-controlled trial of high-dose Mesterolone (cas 1424-00-6)* treatment of idiopathic male infertility)